The Prevent Severe COVID-19 (PRESECO) Study

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316

NCT02026349 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia

NCT04613271 ·Status: COMPLETED ·Phase: PHASE3

MP1032 Treatment in Patients With Moderate to Severe COVID-19

NCT04932941 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions.

NCT07261085 ·Status: ACTIVE_NOT_RECRUITING

Efficacy and Safety of Favipiravir in Management of COVID-19

NCT04349241 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

NCT06667700 ·Status: RECRUITING ·Phase: PHASE3

T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza

NCT01728753 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.

NCT07090486 ·Status: COMPLETED

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

NCT04359680 ·Status: COMPLETED ·Phase: PHASE3

Favipiravir Therapy in Adults With Mild COVID-19

NCT04464408 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19

NCT04346628 ·Status: COMPLETED ·Phase: PHASE2

Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

NCT04542694 ·Status: COMPLETED ·Phase: PHASE3

Philippine Trial to Determine Efficacy and Safety of Favipiravir for COVID-19

NCT05014373 ·Status: UNKNOWN ·Phase: PHASE3

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

NCT05195749 ·Status: TERMINATED ·Phase: PHASE2

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)

NCT05084911 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Tocilizumab on Patients With COVID-19

NCT04356937 ·Status: COMPLETED ·Phase: PHASE3

Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019

NCT04310228 ·Status: UNKNOWN ·Phase: NA

Intravenous Zotatifin in Adults With Mild or Moderate COVID-19

NCT04632381 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of Faviprevir in COVID-19 Treatment

NCT04351295 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of S-892216 in Participants With COVID-19

NCT06928051 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19

NCT05365321 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Clinical Trial of Favipiravir Treatment of Patients With COVID-19

NCT04600999 ·Status: COMPLETED ·Phase: PHASE3

An Adaptive Clinical Trial of Antivirals for COVID-19 Infection

NCT04445467 ·Status: UNKNOWN ·Phase: PHASE2

A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.

NCT04880109 ·Status: TERMINATED ·Phase: PHASE2

A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized

NCT05799495 ·Status: COMPLETED ·Phase: PHASE2